Cargando…
A retrospective comparison of drugs against COVID-19
Coronavirus disease 19 (COVID-19) has posed serious threats to the general population. To relieve the crisis, a comparison of drug effects against COVID-19 is instructive. Between January 27, 2020 and March 21, 2020, a total of 333 patients treated with arbidol, corticosteroids, hydroxychloroquine,...
Autores principales: | Tan, Jiahong, Yuan, Yuan, Xu, Cheng, Song, Chunyan, Liu, Dan, Ma, Ding, Gao, Qinglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833729/ https://www.ncbi.nlm.nih.gov/pubmed/33333102 http://dx.doi.org/10.1016/j.virusres.2020.198262 |
Ejemplares similares
-
Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer
por: Tan, Jiahong, et al.
Publicado: (2021) -
Expression of PAWR predicts prognosis of ovarian cancer
por: Tan, Jiahong, et al.
Publicado: (2020) -
C/EBPβ promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer
por: Tan, Jiahong, et al.
Publicado: (2021) -
Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study
por: Liu, Dan, et al.
Publicado: (2020) -
Heterogeneity of immune microenvironment in ovarian cancer and its clinical significance: a retrospective study
por: Gao, Yue, et al.
Publicado: (2020)